TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29536984

Group type: EXPERIMENTAL
Intervention: WeChat group (WG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional group (TG)
Number of subjects: 80
Study: 27666179

Group type: EXPERIMENTAL
Intervention: US participants (n=3,706)
Number of subjects: 5451

Group type: COMPARATOR
Intervention: Non-US participants (n=1,745)
Number of subjects: 5451

Group type: EXPERIMENTAL
Intervention: US participants hospitalized with unstable angina
Number of subjects: 5451

Group type: COMPARATOR
Intervention: Non-US participants hospitalized with unstable angina
Number of subjects: 5451

Group type: EXPERIMENTAL
Intervention: US geographic disposition
Number of subjects: 5451
Study: 24931587

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 22466027

Group type: EXPERIMENTAL
Intervention: HF-TENS (100 Hz)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: LF-TENS (4 Hz)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 75
Study: 19195824

Group type: COMPARATOR
Intervention: Ceramic-on-conventional polyethylene (CP)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Alumina ceramic-on-ceramic (CC)
Number of subjects: 55
Study: 18308996

Group type: EXPERIMENTAL
Intervention: Citrate 4%
Number of subjects: 61

Group type: COMPARATOR
Intervention: Heparin 5000 U/ml
Number of subjects: 61
Study: 15266308

Group type: EXPERIMENTAL
Intervention: Enteral diet supplemented with arginine (group I, n=14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous enteral formula (group II, n=15)
Number of subjects: 29
Study: 11880817

Group type: EXPERIMENTAL
Intervention: Strength training (S)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Concurrent strength and endurance training (CC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endurance training (E)
Number of subjects: 30
Study: 10084558

Group type: EXPERIMENTAL
Intervention: Low dose short synacthen test (LDSST) - 1 microg tetracosactrin, ACTH-(1-24)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Conventional dose short synacthen test (SST) - 250 microg tetracosactrin, ACTH-(1-24)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Insulin tolerance test (ITT)
Number of subjects: 64
Study: 7752296

Group type: EXPERIMENTAL
Intervention: Clonidine only
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Clonidine and naltrexone
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Clonidine and naloxone
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 152
Study: 2321994

Group type: EXPERIMENTAL
Intervention: Topical 0.05% tretinoin solution applied once a day under tape occlusion or twice a day unoccluded for 4 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo containing 50% alcohol
Number of subjects: 21
Study: 379722

Group type: EXPERIMENTAL
Intervention: Ritodrine (N = 14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (N = 15)
Number of subjects: 29
Study: 31381249

Group type: EXPERIMENTAL
Intervention: Cystectomy group (n = 21)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Non-cystectomy group (n = 336)
Number of subjects: 398
Study: 31474178

Group type: EXPERIMENTAL
Intervention: Variable Resistance Training (VRT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dynamic Constant External Resistance (DCER)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study: 29252022

Group type: EXPERIMENTAL
Intervention: Web-based survey administration (e-mail distribution)
Number of subjects: 132

Group type: COMPARATOR
Intervention: In-clinic survey administration
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Web-based survey administration
Number of subjects: 132
Study: 26156911

Group type: EXPERIMENTAL
Intervention: Midazolam-Fentanyl (MF)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Propofol-Remifentanil (PR)
Number of subjects: 64
Study: 23281420

Group type: EXPERIMENTAL
Intervention: 15 mg intra-articular morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5 mg intra-articular morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 mg intra-articular morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline injection (control group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.5% intra-articular bupivacaine
Number of subjects: 40
Study: 20937715

Group type: EXPERIMENTAL
Intervention: Galvanic vestibular stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platform rotation (20 deg s−1)
Number of subjects: 0
Study: 19337769

Group type: EXPERIMENTAL
Intervention: Sugar cane policosanols (10 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (incorporated in margarine)
Number of subjects: 21
Study: 17262862

Group type: EXPERIMENTAL
Intervention: Chito‐Seal pad
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Clo‐Sur PAD
Number of subjects: 184

Group type: COMPARATOR
Intervention: Manual compression (ACT < 250)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Manual compression (ACT < 170)
Number of subjects: 184
Study: 12913699

Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant hormone therapy (NHT) with 100 mg cyproterone acetate 3 times daily before surgery
Number of subjects: 213

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: 3 months of neoadjuvant hormone therapy (NHT)
Number of subjects: 213
Study: 11064528

Group type: EXPERIMENTAL
Intervention: Expert judgment in routine practice
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Age of the patient
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Patients' belief in effective treatments and perceived ability to cope
Number of subjects: 474
Study: 8829026

Group type: EXPERIMENTAL
Intervention: Ketoprofen gel (2.5% w/w)
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Piroxicam gel (0.5% w/w)
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Diclofenac gel (1% w/w)
Number of subjects: 1575
Study: 1483069

Group type: EXPERIMENTAL
Intervention: Inhaled platelet-activating factor (200 micrograms)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Methacholine (control)
Number of subjects: 6
Study: 3912961

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Transcutaneous electric nerve stimulation (TENS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham treatment for TENS
Number of subjects: 23
Study: 30959227

Group type: EXPERIMENTAL
Intervention: Baseline CRP levels in females
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Baseline CRP levels in males
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: CRP reduction from baseline to week-8
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Changes in HAMD-17 and CRP
Number of subjects: 220
Study: 29107324

Group type: EXPERIMENTAL
Intervention: Afternoon surgery (n=298)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Morning surgery (n=298)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Afternoon surgery (n=44)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Morning surgery (n=44)
Number of subjects: 596
Study: 26015451

Group type: EXPERIMENTAL
Intervention: Exercise training (four times daily at 60% to 70% of VO2max for four weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Exercise training (four weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 120
Study: 25346155

Group type: EXPERIMENTAL
Intervention: OXN PR (combined prolonged-release oxycodone and naloxone)
Number of subjects: 474

Group type: COMPARATOR
Intervention: Oxy PR (oxycodone prolonged-release tablets)
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: OXN PR
Number of subjects: 474
Study: 22169699

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) treatment (3 weekly injections of 2 ml of 20 mg/ml HA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (P) (3 weekly injections of 1.2 ml of 0.001 mg/ml HA)
Number of subjects: 30
Study: 20609251

Group type: EXPERIMENTAL
Intervention: Stepped care intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study: 18032992

Group type: EXPERIMENTAL
Intervention: Video counseling with immediate testing
Number of subjects: 805

Group type: COMPARATOR
Intervention: Standard care (referral to counseling and testing the next day)
Number of subjects: 805
Study: 15859371

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study: 12106842

Group type: EXPERIMENTAL
Intervention: Ultrasonic-derived regional deformation parameters (peak systolic strain rate and systolic strain) in TOF patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultrasonic-derived regional deformation parameters in TOF patients
Number of subjects: 30
Study: 9704607

Group type: EXPERIMENTAL
Intervention: Sequestration patients (hemapheresis with normovolemic hemodilution)
Number of subjects: 160

Group type: COMPARATOR
Intervention: IAT only patients (control group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Sequestration patients
Number of subjects: 160
Study: 7853086

Group type: EXPERIMENTAL
Intervention: Infrared tympanic thermometer
Number of subjects: 34

Group type: COMPARATOR
Intervention: Axillary thermometer
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rectal thermometer
Number of subjects: 34
Study: 2697210

Group type: EXPERIMENTAL
Intervention: methylprednisolone plus low‐dose cyclosporin A (CyA; median dose 109 mg/m2 per day = 3.4 mg/kg per day after 1 year)
Number of subjects: 51

Group type: COMPARATOR
Intervention: methylprednisolone plus azathioprine (AZA)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: methylprednisolone plus low‐dose cyclosporin A (CyA)
Number of subjects: 51
Study: 202141

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30826339

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 132

Group type: COMPARATOR
Intervention: Routine management
Number of subjects: 132
Study: 29870029

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 114

Group type: COMPARATOR
Intervention: Non-metformin (Control)
Number of subjects: 114
Study: 26936907

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily
Number of subjects: 3280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3280
Study: 24880577

Group type: EXPERIMENTAL
Intervention: Retromuscular inset of a lightweight polypropylene mesh
Number of subjects: 57

Group type: COMPARATOR
Intervention: Dual closure of the anterior rectus fascia using Quill self‐locking technology
Number of subjects: 57
Study: 22497697

Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) 200mg twice daily (bid)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Placebo bid
Number of subjects: 596
Study: 19436015

Group type: EXPERIMENTAL
Intervention: 12-month home-based tailored program of telephone counseling and mailed materials promoting exercise, improved diet quality, and modest weight loss.
Number of subjects: 641
Study: 17846101

Group type: EXPERIMENTAL
Intervention: Brief Problem‐Solving Therapy in Home Care (PST‐HC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 40
Study: 15100513

Group type: EXPERIMENTAL
Intervention: Cochlear implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrical stimulation of the promontory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochlear implantation (subset analysis)
Number of subjects: 0
Study: 11428528

Group type: EXPERIMENTAL
Intervention: Progress 3 aspheric multifocal IOL
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional monofocal IOL
Number of subjects: 40
Study: 10179701

Group type: EXPERIMENTAL
Intervention: Economic evaluations in healthcare interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Good quality clinical data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relevant costs and outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appropriate methods of data analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presentation of results
Number of subjects: 0
Study: 8052342

Group type: EXPERIMENTAL
Intervention: Miglitol 200 mg at bedtime
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3053562

Group type: EXPERIMENTAL
Intervention: Amoxycillin with clavulanic acid (Augmentin) for prophylaxis against wound infections
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanate (post-trial)
Number of subjects: 46
Study: 1610673

Group type: EXPERIMENTAL
Intervention: NHS nursing homes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional long stay hospital wards
Number of subjects: 0
Study: 321709

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Penicillin plus Chloramphenicol
Number of subjects: 77
Study: 31340042

Group type: EXPERIMENTAL
Intervention: ChAd155-RSV high dose (5 × 10^10 viral particles)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: ChAd155-RSV low dose (5 × 10^9 viral particles)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: COMPARATOR
Intervention: Active control (Bexsero)
Number of subjects: 72
Study: 27815105

Group type: EXPERIMENTAL
Intervention: Buffered 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-buffered 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 44
Study: 26407616

Group type: EXPERIMENTAL
Intervention: Sub‐fascial continuous local anaesthetic wound infusion (CLAWI) with 0.2% Bupivacaine plus intravenous paracetamol and rescue intravenous morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epidural bupivacaine (EPI) plus paracetamol and rescue intravenous morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous morphine and paracetamol (standard post‐operative analgesia—SAPA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CLAWI group
Number of subjects: 60
Study: 24411121

Group type: EXPERIMENTAL
Intervention: Information intervention
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Resilience intervention
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 220
Study: 22079215

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy (CBT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 20002951

Group type: EXPERIMENTAL
Intervention: Malnutrition Screening Tool (MST)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Subjective Global Assessment (SGA)
Number of subjects: 285
Study: 17320729

Group type: EXPERIMENTAL
Intervention: Subjects with LBP
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy subjects (Control)
Number of subjects: 29
Study: 15562267

Group type: EXPERIMENTAL
Intervention: Methionine load (100 mg/kg of body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11473657

Group type: EXPERIMENTAL
Intervention: NESP (0.45 microg/kg once weekly)
Number of subjects: 166

Group type: COMPARATOR
Intervention: rHuEPO (50 U/kg twice weekly)
Number of subjects: 166
Study: 9675959

Group type: EXPERIMENTAL
Intervention: Carvedilol (50 mg/day)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 8283892

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 11

Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 11
Study: 2921077

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2,160 mg/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (non-Ca group)
Number of subjects: 27
Study: 31906754

Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Micronized Progesterone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 21
Study: 29542251

Group type: EXPERIMENTAL
Intervention: Water aerobic exercise training (WAET)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 26684819

Group type: EXPERIMENTAL
Intervention: IL-7 injections (3 weekly injections at weeks 8, 9, and 10)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IL-7 injections
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: IL-7 injections and dual ART intensification
Number of subjects: 29

Group type: COMPARATOR
Intervention: Intensification alone
Number of subjects: 29
Study: 24853636

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22940889

Group type: EXPERIMENTAL
Intervention: Intravenous iron(III)‐hydroxide sucrose complex, three doses of 100 mg/24 h during pre‐ and postoperative hospitalization and 1 pill/24 h of oral placebo
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Oral ferrous fumarate iron 1 pill/24 h pre‐ and postoperatively and during 1 month after discharge, and intravenous placebo while hospitalized
Number of subjects: 159

Group type: COMPARATOR
Intervention: Oral and intravenous placebo pre‐ and postoperatively
Number of subjects: 159
Study: 20208358

Group type: EXPERIMENTAL
Intervention: D-psicose (5 g)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (0 g)
Number of subjects: 26

Group type: COMPARATOR
Intervention: D-glucose (5 g)
Number of subjects: 26
Study: 18975521

Group type: EXPERIMENTAL
Intervention: Oral verapamil 40 mg every 8 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15754989

Group type: EXPERIMENTAL
Intervention: Heavy marijuana smokers after 24 hours of abstinence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heavy marijuana smokers after 28 days of abstinence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy nonusing controls
Number of subjects: 0
Study: 12007046

Group type: EXPERIMENTAL
Intervention: Outpatient rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient rehabilitation
Number of subjects: 0
Study: 10397379

Group type: EXPERIMENTAL
Intervention: Atovaquone and proguanil (1000 mg and 400 mg respectively, administered orally at 24-hour intervals for 3 doses)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Pyrimethamine/sulfadoxine (75 mg/1500 mg administered orally as a single dose)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Atovaquone and proguanil
Number of subjects: 163

Group type: COMPARATOR
Intervention: Pyrimethamine/sulfadoxine
Number of subjects: 163
Study: 9251266

Group type: EXPERIMENTAL
Intervention: Corneal sensitivity in subjects with diabetes mellitus without retinopathy (1.17 +/- 0.29 gm/mm2)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Corneal sensitivity in eyes with any type of retinopathy (1.94 +/- 1.33 gm/mm2)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Corneal hypoesthesia as a test to detect diabetic retinopathy at a cut off value of 1.20 gm/mm2
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Corneal hypoesthesia for detecting presence of proliferative diabetic retinopathy at a cut off value of 1.49 gm/mm2
Number of subjects: 105
Study: 1735830

Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions
Number of subjects: 35

Group type: COMPARATOR
Intervention: IVIG infusions
Number of subjects: 35
Study: 6538844

Group type: EXPERIMENTAL
Intervention: Cimoxatone, 40 mg oral dose
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 12225492

Group type: EXPERIMENTAL
Intervention: Bech-Rafaelsen Melancholia Scale (MES)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term and long-term treatment
Number of subjects: 0
Study: 29486514

Group type: EXPERIMENTAL
Intervention: ACE-083 (50-200 mg) administered unilaterally into rectus femoris (RF) or tibialis anterior (TA) muscles as 1 or 2 doses 3 weeks apart
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 27810310

Group type: EXPERIMENTAL
Intervention: LU+B420 (12g Litesse® Ultra polydextrose + 1010CFU Bifidobacterium animalisssp. lactis 420)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: B420 (1010CFU/d in microcrystalline cellulose, 12g/d)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: LU (12g/d)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo (microcrystalline cellulose, 12g/d)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: B420 and LU+B420
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: LU+B420
Number of subjects: 225
Study: 25144827

Group type: EXPERIMENTAL
Intervention: Death as a primary endpoint
Number of subjects: 7986

Group type: EXPERIMENTAL
Intervention: Death plus hospitalization as a primary endpoint
Number of subjects: 7986
Study: 22209773

Group type: EXPERIMENTAL
Intervention: Nerve-sparing radical hysterectomy (NSRH)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Radical hysterectomy (RH)
Number of subjects: 25
Study: 20040005

Group type: EXPERIMENTAL
Intervention: XIENCE V everolimus eluting coronary stent system (everolimus doses ranging from 53 to 181 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study: 18784586

Group type: EXPERIMENTAL
Intervention: Intramedullary fixation using an interlocking nail without iliac bone graft
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramedullary fixation using an interlocking nail with iliac bone graft
Number of subjects: 40
Study: 16150687

Group type: EXPERIMENTAL
Intervention: Child Dissociative Checklist (CDC) administered to children with abuse histories
Number of subjects: 94

Group type: COMPARATOR
Intervention: Child Dissociative Checklist (CDC) administered to children with ADHD
Number of subjects: 94

Group type: COMPARATOR
Intervention: Child Dissociative Checklist (CDC) administered to control group (no abuse or psychiatric record)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Correlation analysis of CDC scores and duration of abusive experiences
Number of subjects: 94
Study: 11961325

Group type: EXPERIMENTAL
Intervention: DIAGNOdent laser evaluation
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Clinical examination
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: DIAGNOdent
Number of subjects: 220